Biomarin Pharmaceutical Inc
NASDAQ:BMRN
Biomarin Pharmaceutical Inc
Total Other Income
Biomarin Pharmaceutical Inc
Total Other Income Peer Comparison
Competitive Total Other Income Analysis
Latest Figures & CAGR of Competitors
Company | Total Other Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
|
Total Other Income
$13.4m
|
CAGR 3-Years
11%
|
CAGR 5-Years
28%
|
CAGR 10-Years
31%
|
|
Abbvie Inc
NYSE:ABBV
|
Total Other Income
-$3.5B
|
CAGR 3-Years
12%
|
CAGR 5-Years
-62%
|
CAGR 10-Years
-78%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Total Other Income
$158m
|
CAGR 3-Years
4%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
|
Amgen Inc
NASDAQ:AMGN
|
Total Other Income
$151m
|
CAGR 3-Years
126%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Total Other Income
-$55.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Total Other Income
-$31.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Biomarin Pharmaceutical Inc's Total Other Income?
Total Other Income
13.4m
USD
Based on the financial report for Mar 31, 2024, Biomarin Pharmaceutical Inc's Total Other Income amounts to 13.4m USD.
What is Biomarin Pharmaceutical Inc's Total Other Income growth rate?
Total Other Income CAGR 10Y
31%
The average annual Total Other Income growth rates for Biomarin Pharmaceutical Inc have been 11% over the past three years , 28% over the past five years , and 31% over the past ten years .